Author:
Walker Joan L.,Armstrong Deborah K.,Huang Helen Q.,Fowler Jeffrey,Webster Kenneth,Burger Robert A.,Clarke-Pearson Daniel
Subject
Obstetrics and Gynaecology,Oncology
Reference23 articles.
1. Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer;Alberts;N. Engl. J. Med.,1996
2. Phase III trial of standard-dose intravenous cisplatin plus Paclitaxel versus moderately high-dose carboplatin followed by intravenous Paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group and Eastern Cooperative Oncology Group;Markman;J. Clin. Oncol.,2001
3. Armstrong DK, Bundy B, Wenzel L, et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer: A GOG study. N Engel J Med (in press).
4. Quality of life (QOL) results of a randomized study of intravenous (IV) paclitaxel and cisplatin vs. IV paclitaxel, intraperitoneal (IP) cisplatin and IP paclitaxel in optimal stage III epithelial ovarian cancer (OC): a Gynecologic Oncology Group trial;Wenzel;Proc. ASCO,2004
5. Intraperitoneal catheter outcomes on GOG 172: randomized trial of IV vs. IP chemotherapy in optimal ovarian cancer;Walker;Gynecol. Oncol.,2004
Cited by
286 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献